YETI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Based on the data provided, Yeti Holdings Inc. (YETI) is not a strong buy for a beginner investor with a long-term focus at this moment. While the company has shown positive financial growth and some analysts are optimistic about its future, the current technical indicators, options sentiment, and hedge fund activity suggest caution. Additionally, the stock's near-term trend indicates potential downside, making it less attractive for immediate entry.
The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral at 34.544, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 35.512, with resistance at 37.949. Overall, the technical indicators are mixed, with no strong buy signal.
Financial performance in Q4 2025 showed revenue growth of 6.80% YoY, net income growth of 9.54% YoY, and EPS growth of 19.05% YoY.
Analysts from firms like Roth Capital, B. Riley, and KeyBanc have upgraded the stock to 'Buy' with price targets as high as $60, citing stabilization in key product categories and long-term growth potential.
Hedge funds are selling the stock, with selling activity increasing by 1018.79% over the last quarter.
Analysts from Morgan Stanley and UBS have lowered their price targets, citing weaker FY26 guidance and margin pressures.
Options sentiment is bearish, with a high put-call ratio indicating traders expect further downside.
Stock trend analysis suggests an 80% chance of a -7.95% decline in the next month.
In Q4 2025, Yeti Holdings reported revenue of $583.7 million, up 6.80% YoY. Net income increased to $58.23 million, up 9.54% YoY. EPS rose to 0.75, up 19.05% YoY. However, gross margin dropped to 58.4%, down -2.23% YoY, indicating some pressure on profitability.
Analyst sentiment is mixed. While firms like Roth Capital, B. Riley, and KeyBanc have upgraded the stock to 'Buy' with price targets ranging from $54 to $60, others like Morgan Stanley and UBS have lowered their price targets to $47, citing near-term challenges in margins and investor confidence in growth.
